Key stats
About Invesco Health Care S&P US Select Sector UCITS ETF
Home page
Inception date
Dec 16, 2009
Structure
Irish VCIC
Replication method
Synthetic
Dividend treatment
Capitalizes
Primary advisor
Invesco Investment Management Ltd.
ISIN
IE00B3WMTH43
The investment objective of the Fund is to achieve the net total return performance of the S&P Select Sector Capped 20% Health Care Index (the Reference Index) less fees, expenses and transaction costs.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Stocks100.00%
Health Technology82.97%
Health Services11.34%
Distribution Services3.85%
Retail Trade1.67%
Commercial Services0.17%
Bonds, Cash & Other−0.00%
Cash−0.00%
Stock breakdown by region
North America97.15%
Europe2.85%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
SML4 invests in stocks. The fund's major sectors are Health Technology, with 82.97% stocks, and Health Services, with 11.34% of the basket. The assets are mostly located in the North America region.
SML4 top holdings are Eli Lilly and Company and Johnson & Johnson, occupying 12.56% and 8.56% of the portfolio correspondingly.
No, SML4 doesn't pay dividends to its holders.
SML4 shares are issued by Invesco Ltd. under the brand Invesco. The ETF was launched on Dec 16, 2009, and its management style is Passive.
SML4 expense ratio is 0.14% meaning you'd have to pay 0.14% of your investment to help manage the fund.
SML4 follows the S&P Select Sector Capped 20% Health Care Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
SML4 invests in stocks.